Zimbabwe has turned down a significant American health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential information.
The decision came to light following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative later clarified that the United States was seeking genetic material for research and commercial purposes but refused to share the benefits from future vaccines.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further negotiations to reach a deal suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
This development comes after a comparable situation in Kenya, where a high court suspended a related health funding agreement after legal challenges were filed about the security of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and accountability.
As per reports, 16 African countries have so far signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to provide its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research without any certainty that the end products would be available to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future pandemics.
"This system is designed to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but recommended that talks need to persist since much of the country's HIV programmes relied on international support.
"Where specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.
This impasse underscores the complex debate between receiving much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.